Literature DB >> 17852897

Candidaemia and risk of intraocular infection: a Danish hospital-based cohort study.

Marianne Kirkegaard Karmisholt1, Ulla Hjort, Lars Loumann Knudsen, Henrik Carl Schønheyder.   

Abstract

Intraocular infection is a feared complication in patients with candidaemia. We therefore assessed the current risk and prognosis in Danish candidaemia patients. Candidaemia patients at a Danish university hospital were identified prospectively during a 10-y period, 1995-2004, and ophthalmologic records were retrieved retrospectively. Among 203 incident cases of candidaemia, 86 (42%) were examined at least once by an ophthalmologist. Nine patients had retinitis and 1 patient had endophthalmitis; eye involvement was bilateral in 8 and monocular in 2 patients. Lesions were generally mild and progression was observed in only 1 patient. Surgical treatment was not indicated and the median duration of systemic antifungal therapy was 19 d. The median survival time was 77 d for candidaemia patients with eye involvement, 480 d in candidaemia patients without such an involvement, and only 9 d in candidaemia patients without an ophthalmologic examination. In conclusion, the cumulative rate of intraocular infection was 11.6%, but we suspect an underestimation due to the circumstances of the eye examinations and the rapid death of many patients. We continue to recommend eye examinations for candidaemia patients, but timing seems not to be critical if overt signs of infection are absent, thereby facilitating the use of improved diagnostic methods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852897     DOI: 10.1080/00365540701642120

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

1.  59 eyes with endogenous endophthalmitis- causes, outcomes and mortality in a Danish population between 2000 and 2016.

Authors:  Søren Solborg Bjerrum; Morten la Cour
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-08       Impact factor: 3.117

2.  Duration of treatment for candidemia and risk for late-onset ocular candidiasis.

Authors:  O Blennow; L Tallstedt; B Hedquist; B Gårdlund
Journal:  Infection       Date:  2012-12-02       Impact factor: 3.553

3.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

4.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

5.  Incidence of chorioretinitis and endophthalmitis in hospitalized patients with fungemia.

Authors:  Mohammad Z Siddiqui; Grant M Gebhard; Kinza T Ahmad; Ahmed B Sallam; Eric R Rosenbaum; Sami H Uwaydat
Journal:  Eye (Lond)       Date:  2021-03-08       Impact factor: 3.775

6.  Incidence and clinical predictors of ocular candidiasis in patients with Candida fungemia.

Authors:  Ayesha Khalid; Lisa A Clough; R C Andrew Symons; Jonathan D Mahnken; Lei Dong; Albert J Eid
Journal:  Interdiscip Perspect Infect Dis       Date:  2014-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.